logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Krittiya Korphaisarn

INSERM
H指数:17
被引数:1,851

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment, and follow-up of patients with hepatocellular carcinoma

亚洲适应性ESMO临床实践指南：肝细胞癌的诊断、治疗和随访

ESMO Open
IF8.3
2026-08-010
OAAI
Tan, C. K.; Vogel, A.; Wong, Y. F.; Ho, G. F.; Zhou, J.; Atmakusuma, T. D.; Kulkarni, P.; Kodama, T.; Chon, H. J.; Bello, M.; Yong, W. P.; Hsu, C.; Korphaisarn, K.; Tanasanvimon, S.; Chen, S-C; Lee, S. Y.; Sebastian, M. R.; Huh, S. J.; Morizane, C.; Tiwari, P.; Kalista, K. F.; Qin, S.; Smyth, E. C.; Lim, E.; Hou, T. C.; Pentheroudakis, G.; Shan, C. W.; Andre, F.; Muthukkumaran, T.; Ducreux, M.
Global prevalence of FGFR2b protein overexpression in advanced gastric cancer and gastroesophageal junction cancers: pooled analysis of two bemarituzumab phase III studies

FGFR2b蛋白过表达在晚期胃癌和胃食管结合部癌症中的全球流行率：两项bemarituzumab III期研究的合并分析

ESMO Open
IF8.3
2026-05-260
OAAI
S.B. Maron; R.-H. Xu; Z.A. Wainberg; S.Y. Rha; Y. Zhang; F. Pietrantonio; S.C.S. Oliveira; Y. Li; M.-H. Chen; K. Korphaisarn; E. Elimova; C.A. Calderon; F.V. Herpe; W.P. Yong; T.M. Dos Santos; M. Tan; K. Isse; R.E. Yanes; K. Shitara
Durvalumab following definitive chemoradiotherapy among patients with stage III NSCLC in the Thai population: a real-world; multicenter observational study

度鲁木单抗在泰国人群III期非小细胞肺癌患者中完成根治性放化疗后的应用：一项真实世界、多中心观察性研究

Frontiers in Oncology
IF3.3
2025-10-220
OAAI
Piyada Sitthideatphaiboon; Thanyanan Reungwetwattana; Sureerat Jaruhathai; Archara Supavavej; Piyarat Limpawittayakul; Kunlatida Maneenil; Krittiya Korphaisarn; Thatthan Suksombooncharoen; Luangyot Thongthieang; Chirawadee Sathitruangsak; Chawalit Chayangsu; Hataiwan Ratanabunjerdkul; Naiyarat Prasongsook; Virote Sriuranpong
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancer

泛亚洲适应性ESMO临床实践指南：胰腺癌患者的诊断、治疗和随访

ESMO Open
IF8.3
2025-10-090
OAAI
D. Tai; T. Conroy; J.J.X. Lee; C.E. Chee; C.-Y. Hao; I. Wijaya; S. Aggarwal; M. Ueno; H.-C. Jeung; N.M. Hashim; J. Tan Chun Bing; L.-T. Chen; K. Korphaisarn; S. Tanasanvimon; W.-C. Chou; E. Cargullo; N.F.A. Muin; M.A. Lee; A. Ohba; S. Bondarde; C.R.A. Lesmana; L. Wang; E.C. Smyth; T. Yoshino; G. Bonney; G. Pentheroudakis; J. Samol; A. Cervantes; E. Poon; M. Ducreux
Comprehensive germline and somatic profiling of high-risk Thai breast cancer via next-generation sequencing

通过下一代测序对高危泰国乳腺癌进行全面的种系和体细胞分析

SCIENTIFIC REPORTS
IF3.9
2025-04-030
OAAI
Kamdee, Kornyok; Roothumnong, Ekkapong; Thongnoppakhun, Wanna; Korphaisarn, Krittiya; Nakthong, Panee; Dungort, Peerawat; Meesamarnpong, Chutima; Wiboontanasarn, Supakit; Tansa-nga, Warisara; Punuch, Kittiporn; Pongsuktavorn, Khontawan; Tititumjariya, Warunya; Lertbussarakam, Chittapat; Wattanarangsan, Jantanee; Sritun, Jiraporn; Ridchuayrod, Numpueng; Pithukpakorn, Manop; Suktitipat, Bhoom
Dietary pattern and the corresponding gut microbiome in response to immunotherapy in Thai patients with advanced non-small cell lung cancer (NSCLC)

泰国晚期非小细胞肺癌 (NSCLC) 患者对免疫疗法的饮食模式和相应的肠道微生物组

SCIENTIFIC REPORTS
IF3.9
2024-11-131
OAAI
Sitthideatphaiboon, Piyada; Somlaw, Nicha; Zungsontiporn, Nicha; Ouwongprayoon, Pongsakorn; Sukswai, Narittee; Korphaisarn, Krittiya; Poungvarin, Naravat; Aporntewan, Chatchawit; Vinayanuwattikun, Chanida; Hirankarn, Nattiya; Chanida, Vinayanuwattikun
ALINA: Exploratory biomarker analyses in patients (pts) with resected ALK plus non-small cell lung cancer (NSCLC) treated with adjuvant alectinib vs chemotherapy (chemo)

ALINA：在接受了手术切除的ALK阳性非小细胞肺癌（NSCLC）患者中，接受辅助阿来替尼治疗与接受化疗的患者的探索性生物标志物分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-014
PRE
Solomon, B. J.; Wu, Y-L.; Dziadziuszko, R.; Barlesi, F.; Nishio, M.; Ahn, J. S.; Horinouchi, H.; Hochmair, M. J.; de Marinis, F.; Migliorino, M. R.; Kurochkin, A.; Harputluoglu, H.; Planchard, D.; Korphaisarn, K.; Han, J-Y.; Lohmann, T.; Gavaldon, A. Cardona; Archer, V. R.; Nowicka, M.; Noe, J.
Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries

亚太国家一线阿特珠单抗联合贝伐单抗治疗肝细胞癌后系统治疗的真实世界研究

LIVER CANCER
IF9.1
2024-08-200
OAAI
Lee, Choong-kun; Yoo, Changhoon; Hong, Jung Yong; Park, Se Jun; Kim, Jin Won; Tai, David Wai Meng; Kim, Hyeyeong; Korphaisarn, Krittiya; Tanasanvimon, Suebpong; Chen, San-Chi; Kim, Ju Won; Kim, Ilhwan; Kim, Moonho; Choo, Joan; Oh, Sang-Bo; Chen, Ching-Tso; Bae, Woo Kyun; Kim, Hongsik; Huh, Seok Jae; Yen, Chia-Jui; Park, Sejung; Lee, Dong Ki; Chan, Landon Long; Kang, Beodeul; Kang, Minsu; Sundar, Raghav; Choi, Hye Jin; Chan, Stephen Lam; Chon, Hong Jae; Lee, Myung-Ah
KRAS mutations suppress the tumor immune microenvironment in colorectal cancer
CANCER RESEARCH
IF16.6
2023-04-041
PRE
Tanjak, Pariyada; Chaiboonchoe, Amphun; Suwatthanarak, Tharathorn; Acharayothin, Onchira; Thanormjit, Kullanist; Chanthercrob, Jantappapa; Suwatthanarak, Thanawat; Wannasuphaphol, Bundit; Chumchuen, Kemmapon; Suktitipat, Bhoom; Sampattavanich, Somponnat; Korphaisarn, Krittiya; Pongpaibul, Ananya; Poungvarin, Naravat; Grove, Harald; Riansuwan, Woramin; Trakarnsanga, Atthaphorn; Methasate, Asada; Pithukpakorn, Manop; Chinswangwatanakul, Vitoon
Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma (vol 12, 1021632, 2022)
FRONTIERS IN ONCOLOGY
IF3.3
2023-01-060
OAAI
Prasopporn, Sunisa; Suppramote, Orawan; Ponvilawan, Ben; Jamyuang, Chanette; Chanthercrob, Jantappapa; Chaiboonchoe, Amphun; More-Krong, Pimkanya; Kongsri, Kamonchanok; Suntiparpluacha, Monthira; Chanwat, Rawisak; Korphaisarn, Krittiya; Okada, Seiji; Sampattavanich, Somponnat; Jirawatnotai, Siwanon

研究方向

暂未获取到该数据
C
Charuwan Akewanlop
H 指数:13论文数:93被引数:2,861
P
Piyada Sitthideatphaiboon
H 指数:10论文数:68被引数:621
S
Somponnat Sampattavanich
H 指数:14论文数:70被引数:900
S
Seiji Okada
H 指数:53论文数:561被引数:1.2万
C
Chanida Vinayanuwattikun
H 指数:14论文数:87被引数:540
N
Naiyarat Prasongsook
H 指数:14论文数:65被引数:973
S
Suebpong Tanasanvimon
H 指数:17论文数:108被引数:3,440
S
Scott Kopetz
H 指数:109论文数:1,942被引数:5.7万
J
Jarin Chindaprasirt
H 指数:20论文数:111被引数:1,147
M
Monthira Suntiparpluacha
H 指数:5论文数:12被引数:122